Task: Answer the multiple-choice question.
Query: Which drug exhibits a 0.247% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) Cc1ccc(C)c2c1sc(=NC(=O)CN1C(=O)CCC1=O)n2C
b) CCC(CC)c1nnc(NC(=O)C2COc3ccccc3O2)s1
Answer: b. CCC(CC)c1nnc(NC(=O)C2COc3ccccc3O2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(CC)c1nnc(NC(=O)C2COc3ccccc3O2)s1
CCC(CC)c1nnc(NC(=O)C2COc3ccccc3O2)s1
N-(5-pentan-3-yl-1,3,4-thiadiazol-2-yl)-2,3-dihydro-1,4-benzodioxine-3-carboxamide